These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 9816227
41. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. Field JK, Zoumpourlis V, Spandidos DA, Jones AS. Cancer Detect Prev; 1994; 18(3):197-208. PubMed ID: 8076382 [Abstract] [Full Text] [Related]
42. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Miller CS, Johnstone BM. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):622-35. PubMed ID: 11402272 [Abstract] [Full Text] [Related]
43. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. Mitra S, Banerjee S, Misra C, Singh RK, Roy A, Sengupta A, Panda CK, Roychoudhury S. J Clin Pathol; 2007 Sep; 60(9):1040-7. PubMed ID: 17079356 [Abstract] [Full Text] [Related]
44. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Sanghavi V, Mehta AR. Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843 [Abstract] [Full Text] [Related]
45. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Anticancer Res; 2000 May; 20(2B):1301-5. PubMed ID: 10810439 [Abstract] [Full Text] [Related]
46. [Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses]. Furuta Y. Hokkaido Igaku Zasshi; 1990 Nov; 65(6):568-82. PubMed ID: 2176174 [Abstract] [Full Text] [Related]
47. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Tenti P, Pavanello S, Padovan L, Spinillo A, Vesentini N, Zappatore R, Migliora P, Zara C, Ranzani GN, Carnevali L. Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366 [Abstract] [Full Text] [Related]
48. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Lu DW, El-Mofty SK, Wang HL. Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066 [Abstract] [Full Text] [Related]
49. p53 gene mutations are rare in human papillomavirus-associated colon cancer. Buyru N, Budak M, Yazici H, Dalay N. Oncol Rep; 2003 Jul; 10(6):2089-92. PubMed ID: 14534749 [Abstract] [Full Text] [Related]
50. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. J Exp Clin Cancer Res; 2004 Dec; 23(4):561-6. PubMed ID: 15743024 [Abstract] [Full Text] [Related]
51. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P, Schwarz E, Kahn T. Cancer Lett; 2005 Feb 10; 218(2):199-206. PubMed ID: 15670897 [Abstract] [Full Text] [Related]
52. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. J Natl Cancer Inst; 2008 Mar 19; 100(6):407-20. PubMed ID: 18334711 [Abstract] [Full Text] [Related]
53. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Rosenquist K. Swed Dent J Suppl; 2005 Mar 19; (179):1-66. PubMed ID: 16335030 [Abstract] [Full Text] [Related]
54. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. Liang XH, Lewis J, Foote R, Smith D, Kademani D. J Oral Maxillofac Surg; 2008 Sep 19; 66(9):1875-80. PubMed ID: 18718395 [Abstract] [Full Text] [Related]
55. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Head Neck; 2002 May 19; 24(5):417-22. PubMed ID: 12001070 [Abstract] [Full Text] [Related]
56. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J. Prostate; 1996 May 19; 28(5):318-24. PubMed ID: 8610059 [Abstract] [Full Text] [Related]
57. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA. Cancer Res; 1993 Apr 01; 53(7):1676-83. PubMed ID: 8453641 [Abstract] [Full Text] [Related]
58. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D. N Engl J Med; 1995 Feb 16; 332(7):429-35. PubMed ID: 7619114 [Abstract] [Full Text] [Related]
59. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer. Sauter ER, Ridge JA, Litwin S, Langer CJ. Clin Cancer Res; 1995 Nov 16; 1(11):1407-12. PubMed ID: 9815938 [Abstract] [Full Text] [Related]
60. p53 mutations in HPV-negative cervical carcinoma. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP. Oncogene; 1994 Jan 16; 9(1):205-10. PubMed ID: 8302581 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]